Stapokibart, a novel monoclonal antibody targeting the interleukin 4 receptor α subunit: Promising results in a retrospective cohort of patients with bullous pemphigoid
Fields of Study & Subjects
Autoimmune Bullous Skin Diseases
Dermatology and Skin Diseases
Psoriasis: Treatment and Pathogenesis
Publication details
- Journal / source
- JAAD Case Reports
- Publisher
- Elsevier BV
- Volume
- 76
- Pages
- 191–196
- Publication date
- 14 July 2026
- Language
- EN